Sugi Predict

Sugi Predict / Compounds / SCHEMBL4147953

SCHEMBL4147953

SCHEMBL4147953

O=C(O)c1c(O)cccc1Br

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA12 O43570 5/20 0.70
▸ CA1 P00915 5/20 0.70
▸ CA2 P00918 5/20 0.70
▸ CA7 P43166 5/20 0.70
▸ CA9 Q16790 5/20 0.70
▸ CA14 Q9ULX7 5/20 0.70
▸ THRB P10828 1/20 0.48
▸ BID P55957 4/20 0.43
▸ MCL1 Q07820 4/20 0.43
▸ BCL2L1 Q07817 3/20 0.43
▸ BAK1 Q16611 3/20 0.43
▸ KAT8 Q9H7Z6 2/20 0.43
▸ PPARG P37231 1/20 0.43
▸ PPARA Q07869 1/20 0.43
▸ EP300 Q09472 1/20 0.43
▸ KAT2A Q92830 1/20 0.43
▸ KAT2B Q92831 1/20 0.43
▸ KAT5 Q92993 1/20 0.43
▸ SAE1 Q9UBE0 1/20 0.43
▸ PRNP P04156 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Thiophene SCHEMBL27585523 0.89 CA12 (0.55) CA12CA1CA2CA7CA9
SCHEMBL570378 0.85 CA12 (0.52) CA12CA1CA2CA7CA9
SCHEMBL224031 0.83 CA1 (1.00) CA12CA1CA2CA7CA9
SCHEMBL5603402 0.83 CA1 (1.00) CA12CA1CA2CA7CA9
SCHEMBL29958629 0.82 THRB (0.74) CA12CA1CA2CA7CA9
SCHEMBL3712557 0.82 THRB (0.74) CA12CA1CA2CA7CA9
SCHEMBL8213147 0.80 CA1 (0.94) CA12CA1CA2CA7CA9
SCHEMBL8921906 0.80 CA1 (0.94) CA12CA1CA2CA7CA9
Hydrochloric Acid SCHEMBL8394452 0.80 CA1 (0.94) CA12CA1CA2CA7CA9
Water SCHEMBL30558201 0.80 CA1 (0.94) CA12CA1CA2CA7CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 75 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115722210-B Recursive nanofiber-based detection material and preparation method and application thereof 广西大学 2024-02-20 — — CN claimed
CN-115722210-A Recursive nanofiber-based detection material and preparation method and application thereof 广西大学 2023-03-03 — — CN claimed
US-20260085056-A1 OX1 RECEPTOR ANTAGONISTS NXERA PHARMA UK LIMITED (GB) 2026-03-26 — — US disclosed
US-20250214920-A1 METHOD FOR PRODUCING CYCLIC DIKETONE COMPOUND KAO CORPORATION (JP) 2025-07-03 — — US disclosed
US-20250214921-A1 METHOD FOR PRODUCING CYCLIC DIKETONE COMPOUND KAO CORPORATION (JP) 2025-07-03 — — US disclosed
CN-120195931-A Colored resin composition, color filter and display device 住友化学株式会社 2025-06-24 — — CN disclosed
CN-120195932-A Colored resin composition, color filter and display device 住友化学株式会社 2025-06-24 — — CN disclosed
US-12331029-B2 Orexin 1 receptor antagonists NXERA PHARMA UK LIMITED (GB) 2025-06-17 — — US disclosed
CN-119591637-A Compound with aryl amide structure and medical application thereof 南京芩领医药科技有限公司 2025-03-11 — — CN disclosed
EP-4501896-A1 METHOD FOR PRODUCING CYCLIC DIKETONE COMPOUND Kao Corporation (JP) 2025-02-05 — — EP disclosed
EP-4501897-A1 METHOD FOR PRODUCING CYCLIC DIKETONE COMPOUND Kao Corporation (JP) 2025-02-05 — — EP disclosed
EP-1711478-A2 BENZO [D]ISOXAZOL-3-OL DAAO INHIBITORS Sepracor Inc. (US) 2006-10-18 — — EP disclosed
WO-2006105193-A2 PERSONAL CARE COMPOSITIONS WITH COLOR CHANGING INDICATOR C2C TECHNOLOGIES LLC (US) 2006-10-05 — — WO disclosed
WO-2006105261-A1 CLEANSING COMPOSITIONS WITH COLOR CHANGING INDICATOR C2C TECHNOLOGIES LLC (US) 2006-10-05 — — WO disclosed
WO-2006105260-A1 ORAL CARE COMPOSITIONS WITH COLOR CHANGING INDICATOR C2C TECHNOLOGIES LLC (US) 2006-10-05 — — WO disclosed
WO-2006105191-A2 NOVELTY COMPOSITIONS WITH COLOR CHANGING INDICATOR C2C TECHNOLOGIES LLC (US) 2006-10-05 — — WO disclosed
US-20060222675-A1 Personal care compositions with color changing indicator C2C TECHNOLOGIES, LLC 2006-10-05 — — US disclosed
US-20060222601-A1 Oral care compositions with color changing indicator C2C TECHNOLOGIES, LLC 2006-10-05 — — US disclosed
WO-2005066143-A2 BENZO[D]ISOXAZOL-3-OL DAAO INHIBITORS SEPRACOR INC. (US) 2005-07-21 — — WO disclosed
US-20050143434-A1 Benzo[d]isoxazol-3-ol DAAO inhibitors SEPRACOR INC. (US) 2005-06-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250214920-A1 METHOD FOR PRODUCING CYCLIC DIKETONE COMPOUND CYP4F2, DUOX1, BCKDK CA12 1156/4885CA1 1048/4885CA2 2198/4885
US-20060222675-A1 Personal care compositions with color changing indicator CUTA, POLR1C, TYR CA12 2044/4885CA1 1814/4885CA2 253/4885
US-20050143434-A1 Benzo[d]isoxazol-3-ol DAAO inhibitors DDO, DAO, CACNA1S CA12 981/4885CA1 25/4885CA2 110/4885
US-20250214921-A1 METHOD FOR PRODUCING CYCLIC DIKETONE COMPOUND HSD17B7, HSD17B12, BCKDK CA12 2616/4885CA1 2942/4885CA2 3272/4885
US-20260085056-A1 OX1 RECEPTOR ANTAGONISTS CNR1, CNR2, OPRM1 CA12 1803/4885CA1 894/4885CA2 944/4885
US-12331029-B2 Orexin 1 receptor antagonists HCRTR1, HCRTR2, NPY1R CA12 3917/4885CA1 1290/4885CA2 1787/4885
US-20060222601-A1 Oral care compositions with color changing indicator CA9, CA7, TAS2R7 CA12 38/4885CA1 70/4885CA2 29/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.